• 경제분석
• /
• 제26권3호
• /
• pp.48-70
• /
• 2020

본 연구는 1994~2016년 '가계동향조사'의 미시자료 변수를 표본평균으로 전환하는 방식의 코호트 접근법을 사용하여 소비 불확실성이 존재하는 상황에서 예비적 저축 동기를 추정하였다. 이를 위해 오일러 방정식을 이용하여 도출된 상대적 신중도와 유동성 제약 관련 최초 소득을 통제한 회귀모형을 추정함으로써 예비적 저축 동기 여부를 살펴보았다. 추정 결과, 2SLS 집단 간 추정량(BE2SLS)의 경우 선행연구의 결과와 유사하게 상대적 신중도가 작게 추정되어 예비적 저축 동기가 존재한다고 보기 어려웠다. 반면, 2SLS 확률효과 추정량(RE2SLS)을 사용한 경우에는 예비적 저축 동기가 존재하는 것으로 나타났다. 또한, 유동성 제약 여부를 기준으로 나눈 그룹별 추정에서 유동성 제약 그룹이 미래의 불확실성에 더 민감하게 반응하는 것으로 나타났다.

• Annals of Geriatric Medicine and Research
• /
• 제20권3호
• /
• pp.114-117
• /
• 2016

A research project, the "Construction of Frailty Cohort for Elderly and Intervention Study," funded by the Ministry of Health and Welfare, has been ongoing since December 2015. The Korean Frailty and Aging Cohort Study (KFACS) aims to identify risk factors for adverse outcomes associated with frailty in community-dwelling older adults, as well as means of prevention. KFACS is a multicenter, longitudinal study, with the baseline survey being conducted in 2016-2017. The sample (n=3,000) consists of those aged 70-84 years, stratified by age and gender, recruited from urban and rural regions nationwide. An in-person interview and health examination are performed every 2 years. This project is also conducting many intervention studies. Project interventions focus on nutrition and exercise. The nutritional intervention study compares the effects of 1.2 g/kg versus 1.5 g/kg daily protein intake on sarcopenia and frailty in older Koreans. The exercise trial examines the effectiveness of an information and communication technology-based program in preventing or reducing frailty.

• 한방재활의학과학회지
• /
• 제27권3호
• /
• pp.117-124
• /
• 2017

Objectives Collaboration medicine means cooperate with western medicine and traditional korean medicine to treat the one disease. In Korea, Interest in collaboration medicine is increasing, But the number of studies is scare. Therefore we will conduct collaboration medicine study for the low back pain. Methods This study composes prospective cohort registry study. If the patients who need collaboration medicine by doctor come, we will ask regist this study. And patient select collaboration treatment group and single treatment group. Total 120 patients will recruit from collaboration pilot project hospitals. Each group patient will observed 4 weeks. Telephone research will conducted after 1 month from the last follow up. During the treatment, patients are treated usual treatment type of each medicine. Primary outcome is NRS and secondary outcomes are EQ-5D and ODI. We will analyze difference of 1 week and 4 week outcome result. Conclusions This study is the first large sample size study effect of collaboration medicine in Korea for low back pain. We check present collaboration system and improve collaboration system. Aim of this study is to find the effectiveness collaboration medicine for low back pain in the real condition. And we expect this pilot study will provide the clinical collaboration information and basis.

• 대한방사선기술학회지:방사선기술과학
• /
• 제43권1호
• /
• pp.23-27
• /
• 2020

In South Korea, female individuals in their forties show a high rate of incidence, with approximately 13% of the patients being <40 years. This statistic is more than twice as high as that in Western countries. It is therefore necessary to identify the risk factors for breast cancer incidence by age and economic activity participation status. Women aged 30 to 59-whether breast cancer patients or those in the control group and having no breast cancer-were appraised from the sample cohort database. The data were analyzed using the statistical software R36.2. To identify the factors affecting breast cancer incidence, the degree of association was determined with HR and 95% CI by means of cox regression analysis. As for the socio-demographic variables, the older the individual, the higher the risk of breast cancer incidence becomes. As for the economic activity variables, those who were dependents (unemployed) and who had higher income (medium and high) were at higher risk of breast cancer incidence, which was statistically significant. The income-adjusted HR (model 1) for breast cancer development associated with the economic activity was 1.452 (95% CI, 1.19-1.77). The body mass index and alcohol intake-adjusted HR (model 2) was 1.431 (95% CI, 1.18-1.74). One needs to pay attention to policy plans regarding women's quality of life, as well as to the risk of breast cancer incidence by their economic activity. In other words, policies need to give post care, instead of focus on early detection and cancer treatment.